Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 17;58(7):943.
doi: 10.3390/medicina58070943.

Scar-Free Laparoscopy in BRCA-Mutated Women

Stefano Restaino  1 , Angelo Finelli  2 , Giulia Pellecchia  3 , Anna Biasioli  1 , Jessica Mauro  4 , Carlo Ronsini  5 , Monica Della Martina  1 , Martina Arcieri  3 , Luigi Della Corte  6 , Felice Sorrentino  7 , Lorenza Driul  1   4 , Giuseppe Vizzielli  1   4
Affiliations
Case Reports

Scar-Free Laparoscopy in BRCA-Mutated Women

Stefano Restaino et al. Medicina (Kaunas). .

Abstract

Background and Objectives: BRCA 1 and 2 mutations have a cumulative risk of developing ovarian cancer at 70 years of 41% and 15%, respectively, while a cumulative risk of breast cancer by 80 years of age was 72% for BRCA1 mutation carriers and 69% for BRCA2 mutation carriers. The NCCN recommends risk-reducing salpingo-oophorectomy (RRSO), typically between 35 and 40 years, and upon completion of childbearing in BRCA1 mutation, while it is reasonable to delay RRSO for management of ovarian cancer risk until age 40-45 years in patients with BRCA2. In recent years there have been two main lines of evolution in laparoscopy. The former concerning the development of a single-site laparoscopic and the latter concerning the miniaturisation of laparoscopic instruments (mini/micro-laparoscopy). Materials and Methods: In this case report, we show our experience in prophylactic adnexectomy, on a mutated-BRCA patient, using the MiniLap® percutaneous surgical system. Results: This type of technique is safe and effective and does not require a particular learning curve compared to single-port laparoscopy. Conclusions: The considerable aesthetic advantage of the scars, we believe, albeit to a lesser extent, is useful to find in these patients burdened by an important stress load.

Keywords: BRCA; laparoscopy; oncology; percutaneous; scar free.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
MiniLap® skin accesses.
Figure 2
Figure 2
Step-by-step procedure.
See this image and copyright information in PMC

References

    1. Kuchenbaecker K.B., Hopper J.L., Barnes D.R., Phillips K.-A., Mooij T.M., Roos-Blom M.-J., Jervis S., van Leeuwen F.E., Milne R.L., Andrieu A.N., et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402–2416. doi: 10.1001/jama.2017.7112. - DOI - PubMed
    1. NCCN.org; [(accessed on 24 November 2021)]. Genetic/FamilialHigh-Risk Assessment: Breast, Ovarian, and Pancreatic Version 1.2022—11 August 2021. Available online: https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf.
    1. Metcalfe K.A., Price M.A., Mansfield C., Hallett D.C., Lindeman G.J., Fairchild A., Posner J., Friedman S., Snyder C., Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer et al. Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: An international analysis. Br. J. Cancer. 2020;123:268–274. doi: 10.1038/s41416-020-0861-3. - DOI - PMC - PubMed
    1. Dowdy S.C., Stefanek M., Hartmann L.C. Surgical risk reduction: Prophylactic salpingo-oophorectomy and prophylactic mastectomy. Am. J. Obstet. Gynecol. 2004;191:1113–1123. doi: 10.1016/j.ajog.2004.04.028. - DOI - PubMed
    1. Pinsky P.F., Yu K., Kramer B.S., Black A., Buys S.S., Partridge E., Gohagan J., Berg C.D., Prorok P.C. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up. Gynecol. Oncol. 2016;143:270–275. doi: 10.1016/j.ygyno.2016.08.334. - DOI - PMC - PubMed

Publication types